Capricor Therapeutics CAPR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $105.42M-63.4% | $287.85M+1,375% | $19.51M-16.1% | $23.24M-19.3% | $28.79M+155% | ||
| $173.19M+472% | $30.28M-61.7% | $79.06M-20.6% | $99.56M-14.2% | $115.98M-17.3% | ||
| $4.48M-5.7% | $4.75M+104% | $2.33M+83.7% | $1.27M-10.4% | $1.41M-5.8% | ||
| $283.09M-12.3% | $322.94M+220% | $100.95M-18.7% | $124.13M-15.1% | $146.25M-10.5% | ||
| $28.5M+55.6% | $18.31M+65.5% | $11.07M+38.4% | $8M+30.3% | $6.13M+10.3% | ||
| $13.16M-2.8% | $13.54M-2.8% | $13.93M+1,383% | $939.2K-16.7% | $1.13M-14.1% | ||
| $1.53M+32.3% | $1.16M+137% | $488.74K-3.8% | $508K+100% | $253.37K+14.3% | ||
| $326.28M-8.3% | $355.95M+182% | $126.44M-5.3% | $133.57M-13.1% | $153.77M-9.8% | ||
| $3.93M+137% | $1.65M-39.2% | $2.72M-43.5% | $4.81M-8.4% | $5.25M+60.0% | ||
| $10.53M-32.3% | $15.56M+56.6% | $9.93M— | —— | —— | ||
| $12M0.0% | $12M0.0% | $12M0.0% | $12M0.0% | $12M0.0% | ||
| $841.14K+316% | $202.38K+68.5% | $120.09K-85.9% | $849.51K+0.9% | $842.1K+0.9% | ||
| $33.64M-6.1% | $35.84M+27.3% | $28.15M-0.9% | $28.4M+27.1% | $22.34M+6.2% | ||
| $13.94M-2.6% | $14.32M-0.7% | $14.42M+7,311% | $194.6K-52.2% | $407.39K-33.9% | ||
| $14.78M+1.8% | $14.52M-0.1% | $14.54M+1,293% | $1.04M-16.4% | $1.25M-13.9% | ||
| $13.94M-2.6% | $14.32M-0.7% | $14.42M+7,311% | $194.6K-94.9% | $3.78M-5.2% | ||
| $47.58M-5.1% | $50.16M+17.8% | $42.57M+48.9% | $28.59M+9.5% | $26.12M+4.4% | ||
| —— | —— | —— | —— | —— | ||
| $57.67K+0.5% | $57.37K+25.5% | $45.72K0.0% | $45.71K+0.1% | $45.68K+0.2% | ||
| $617.72M+1.2% | $610.33M+70.6% | $357.68M+1.1% | $353.68M+1.0% | $350.01M+1.7% | ||
| -$338.82M-11.1% | -$304.88M-11.0% | -$274.71M-9.8% | -$250.14M-11.6% | -$224.23M-12.2% | ||
| -$253.73K-190% | $283.15K-66.5% | $844.12K-39.2% | $1.39M-23.4% | $1.81M+76.4% | ||
| $278.7M-8.9% | $305.79M+265% | $83.87M-20.1% | $104.98M-17.8% | $127.65M-12.2% | ||
| $326.28M-8.3% | $355.95M+182% | $126.44M-5.3% | $133.57M-13.1% | $153.77M-9.8% | ||
| —— | —— | —— | —— | —— | ||
| $13.16M-2.8% | $13.54M-2.8% | $13.93M+1,383% | $939.2K-16.7% | $1.13M-14.1% | ||
| $13.16M-2.8% | $13.54M-2.8% | $13.93M+1,383% | $939.2K-16.7% | $1.13M-14.1% | ||
| $1.53M+32.3% | $1.16M+137% | $488.74K-3.8% | $508K+100% | $253.37K+14.3% | ||
| $13.16M-2.8% | $13.54M-2.8% | $13.93M+1,383% | $939.2K-16.7% | $1.13M-14.1% | ||
| $10.53M-32.3% | $15.56M+56.6% | $9.93M— | —— | —— | ||
| $10.53M-32.3% | $15.56M+56.6% | $9.93M— | —— | —— | ||
| $14.78M+1.8% | $14.52M-0.1% | $14.54M+1,293% | $1.04M-16.4% | $1.25M-13.9% | ||
| $617.72M+1.2% | $610.33M+70.6% | $357.68M+1.1% | $353.68M+1.0% | $350.01M+1.7% | ||
| $57.67K+0.5% | $57.37K+25.5% | $45.72K0.0% | $45.71K+0.1% | $45.68K+0.2% | ||
| $6.34M— | —— | —— | —— | —— | ||
| $0-100% | $59.17K0.0% | $59.17K-0.6% | $59.51K-0.5% | $59.83K-99.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Capricor Therapeutics's total assets?
- Capricor Therapeutics (CAPR) holds $326.3M in total assets, up 112.2% year over year.
- How much debt does Capricor Therapeutics have?
- Capricor Therapeutics carries $14.8M in total debt against $278.7M of shareholders' equity, a debt-to-equity ratio of 0.05.
- How much cash does Capricor Therapeutics have?
- Capricor Therapeutics holds $105.4M in cash and equivalents.
- Can Capricor Therapeutics cover its short-term obligations?
- Its current ratio is 8.42 — current assets exceed current liabilities.
- Where does Capricor Therapeutics's balance sheet data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.